VALBIOTIS (EPA:ALVAL) | WebDisclosure

PRESS RELEASE

published on 02/17/2025 at 12:00, 1 year 6 months ago

VALBIOTIS SA: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
VALBIOTIS SA publie des informations mensuelles sur le nombre total de droits de vote et d'actions en circulation. L'entreprise est spécialisée dans les compléments alimentaires pour la prévention des maladies cardiovasculaires

Droits De Vote Capital Social Compléments Alimentaires Maladies Cardiovasculaires Valbiotis SA
BRIEF

published on 01/30/2025 at 17:45, 1 year 6 months ago

Valbiotis to Launch Valbiotis®PRO Metabolic Health in February

Valbiotis Metabolic Health Dietary Supplement TOTUM•63 France Launch
BRIEF

published on 01/30/2025 at 17:45, 1 year 6 months ago

Valbiotis lance Valbiotis®PRO Metabolic Health en février

Valbiotis Santé Métabolique Complément Alimentaire TOTUM•63 Lancement En France
PRESS RELEASE

published on 01/30/2025 at 17:40, 1 year 6 months ago

VALBIOTIS SA: Valbiotis to launch its solution for the prevention of metabolic diseases, Valbiotis®PRO Metabolic Health (Totum•63), on February 3rd
Valbiotis announces the market launch of Valbiotis®PRO Metabolic Health (Totum•63) in France on February 3rd, providing a natural, plant-based solution for metabolic diseases

Valbiotis Metabolic Diseases Metabolic Health Dietary Supplement TOTUM•63
PRESS RELEASE

published on 01/30/2025 at 17:40, 1 year 6 months ago

VALBIOTIS SA: Valbiotis commercialisera dès le 3 février prochain sa solution Valbiotis®PRO Santé métabolique (Totum•63) pour la prévention des maladies métaboliques
Valbiotis SA va commercialiser Valbiotis®PRO Santé métabolique (Totum•63) pour la prévention des maladies métaboliques à partir du 3 février, basée sur TOTUM•63 et stratégie multicanal

Valbiotis SA TOTUM•63 Valbiotis®PRO Santé Métabolique Prévention Maladies Métaboliques Stratégie Multicanal
BRIEF

published on 01/21/2025 at 17:45, 1 year 6 months ago

Valbiotis Outlines 2030 Strategic and Financial Targets

Financial Targets Valbiotis International Sales 2030 Goals Cardiometabolic
BRIEF

published on 01/21/2025 at 17:45, 1 year 6 months ago

Valbiotis présente ses objectifs stratégiques et financiers à horizon 2030

Objectifs Financiers Valbiotis Ventes Internationales Objectifs 2030 Cardiométabolique
PRESS RELEASE

published on 01/21/2025 at 17:40, 1 year 6 months ago

VALBIOTIS SA: Valbiotis unveils its strategic and financial goals for 2030
Valbiotis unveils its strategic and financial goals for 2030, focusing on product releases, turnover targets, and international sales expansion. Detailed roadmap and value proposition presented

Valbiotis Strategic Goals International Sales Financial Goals Product Releases
PRESS RELEASE

published on 01/21/2025 at 17:40, 1 year 6 months ago

VALBIOTIS SA: Valbiotis dévoile ses ambitions stratégiques et financières à horizon 2030
Valbiotis dévoile ses ambitions stratégiques et financières à horizon 2030 avec trois produits pour la prise en charge des troubles cardio-métaboliques sur le marché en France dès 2025

Commercialisation Valbiotis Ambitions Stratégiques Financières Cardio-métaboliques
BRIEF

published on 01/14/2025 at 17:49, 1 year 7 months ago

Valbiotis Announces Success in HEART II Study on Lipidrive

Valbiotis Lipidrive Hypercholesterolemia HEART II Study LDL Cholesterol

Published on 08/20/2026 at 15:30, 1 hour 44 minutes ago

Caldwell Announces Promotion of Lindsay Schoen Lane to Partner
Published on 08/20/2026 at 15:15, 1 hour 59 minutes ago

Reporting Results for the Six Months Ended June 30, 2026
Published on 08/20/2026 at 15:00, 2 hours 14 minutes ago

Portfolio Update - Strategic Investment in Maravilla Oil and Gas
Published on 08/20/2026 at 15:00, 2 hours 14 minutes ago

Vox Royalty Enters into Binding Agreement to Acquire Australian Copper and Gold Royalty Portfolio
Published on 08/20/2026 at 14:35, 2 hours 39 minutes ago

Wi2Wi Reports 59% Revenue Growth to US$2.32M and Returns to Profitability with US$251K Net Income in Q2 2026

View all ACCESSWIRE

Published on 08/20/2026 at 16:20, 53 minutes ago

Holding(s) in Company
Published on 08/20/2026 at 15:45, 1 hour 28 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/20/2026 at 15:45, 1 hour 29 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 08/20/2026 at 15:44, 1 hour 29 minutes ago

Form 8.3 - The Vanguard Group, Inc.: SEGRO plc
Published on 08/20/2026 at 15:43, 1 hour 30 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Schroders plc

View all EQS

Published on 08/18/2026 at 18:00, 1 day 23 hours ago

KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 1 day 23 hours ago

Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 2 days 5 hours ago

GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 2 days 5 hours ago

GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 2 days 21 hours ago

Aéroports de Paris S.A - July 2026 traffic figures

View all LES ECHOS COMFI WIRE

News